Citations

Clear

4847 citation(s) found for "Yu, Eric".

Effect of 3-Dimensional Virtual Reality Models for Surgical Planning of Robotic-Assisted Partial Nephrectomy on Surgical Outcomes
Shirk, Joseph D. , Thiel, David D. , Wallen, Eric, Linehan, Jennifer, White, Wesley M. , Badani, Ketan K. , Porter, James

Mayo Clinic

JAMA Network Open | September 18, 2019 | Volume: 2 | Issue: 9 | Pages: e1911598

10.1001/jamanetworkopen.2019.11598 | PMID 31532520 Get It

Contribution of Inherited DNA-Repair Gene Mutations to Hormone-Sensitive and Castrate-Resistant Metastatic Prostate Cancer and Implications for Clinical Outcome
Yadav, Siddhartha , Hu, Chunling , Hart, Steven N. , Hillman, David, Lee, Kun Y. , Gnanaolivu, Rohan , Na, Jie , Polley, Eric C. , Kohli, Manish , Yadav, Siddhartha , Hu, Chunling , Hillman, David W. , Couch, Fergus J.

Mayo Clinic

JCO Precision Oncology | September 17, 2019 | Volume: No volume available | Issue: 3 | Pages: 1-12

10.1200/po.19.00067 | PMID 32923857 Get It

PURPOSE To compare the prevalence of germline mutations in metastatic hormone-sensitive prostate cancer (mHSPC) and metastatic castrate-resistant prostate cancer (mCRPC) and assess the impact of mutations on progression to castration resistance and overall survival. METHODS Targeted sequencing of germline DNA from 704 men (221 at the time of mHSPC and 483 at the time of mCRPC) enrolled in two advanced prostate cancer registries at Mayo Clinic between 2003 and 2013 was performed for 21 predisposition genes. Frequencies of pathogenic mutations were compared in patients and reference controls to identify genes enriched in metastatic prostate cancer. Multivariable Cox proportional hazards regression was used to identify predictors of progression to mCRPC and overall survival. RESULTS Sixty-eight germline mutations in 12 genes were identified in 66 men (9.4%). Mutations in ATM, BRCA2, CHEK2, FANCM, and TP53 were significantly enriched (odds ratio greater than 2.0) in the metastatic cohorts compared with reference controls. The frequency of germline mutations was similar for patients with mHSPC and mCRPC (11.8% v 8.3%; P = .16). The median time to progression from mHSPC to mCRPC was 23.1 and 32.5 months for patients with and without mutations, respectively ( P = .96). Although older age at diagnosis, Gleason score greater than 7, elevated alkaline phosphatase level, and high volume of disease were associated with shorter duration of progression to mCRPC and poor overall survival, mutation status was not (progression to mCRPC hazard ratio, 0.81; 95% CI, 0.61 to 1.09; P = .17; overall survival hazard ratio, 1.00; 95% CI, 0.75 to 1.34; P = .98). CONCLUSION Similarly elevated rates of germline predisposition gene mutations in mHSPC and mCRPC suggest that germline genetic testing may help to guide medical management for all patients with advanced metastatic prostate cancer. Mutation status was not associated with shorter progression to mCRPC or poor overall survival.
Ongoing and Focused Provider Performance Evaluations in Emergency Medicine: Current Practices and Modified Delphi to Guide Future Practice
Walker, Laura , Phelan, Michael , Bitner, Matthew , Legome, Eric , Tomaszewski, Christian, Strauss, Robert W., Nestler, David M. , Walker, Laura E

Mayo Clinic

American Journal of Medical Quality | September 13, 2019 | Volume: 35 | Issue: 4 | Pages: 306-314

10.1177/1062860619874113 | PMID 31516026 Get It

The Joint Commission requires ongoing and focused provider performance evaluations (OPPEs/FPPEs). The authors aim to describe current approaches in emergency medicine (EM) and identify consensus-based best practice recommendations. An online survey was distributed to leaders in EM to gain insight into current practices. A modified Delphi approach was then used to develop consensus to recommend best practice. A variety of strategies are currently in use for OPPE/FPPE. “Peer reviewed cases with opportunity for improvement” was identified as a preferred metric for OPPE. Although the preference was for use of peer review in OPPE, a consistent and standard adoption of robust internal care review processes is needed to establish expected norms. National benchmarking is not available currently. This was a limited survey of self-identified leaders, and there is an opportunity for additional engagement of leaders in EM to identify a unified approach that appropriately relates to patient outcomes.
Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology
Benson, Al B. , Al-Hawary, Mahmoud M. , Arain, Mustafa A., Chen, Yi‐Jen , Ciombor, Kristen K. , Cooper, Harry S. , Deming, Dustin A. , Garrido‐Laguna, Ignacio , Grem, Jean L. , Hoffe, Sarah E. , Hunt, Steven R., Kamel, Ahmed, Kirilcuk, Natalie, Krishnamurthi, Smitha , Messersmith, Wells A. , Meyerhardt, Jeffrey A. , Miller, Eric D. , Mulcahy, Mary F. , Nurkin, Steven, Overman, Michael J. , Parikh, Aparna, Patel, Hitendra , Pedersen, Katrina S. , Shibata, David , Skibber, John M., Sofocleous, Constantinos T. , Stotsky‐Himelfarb, Eden, Willett, Christopher G. , Johnson-Chilla, Alyse, Gregory, Kristina M., Gurski, Lisa A., Hubbard, Joleen, Miller, Eric D. , Meyerhardt, Jeffrey A , Pedersen, Katrina , Venook, Alan P. , Cohen, Stacey A. , Hubbard, Joleen M. , Patel, Hitendra, Saltz, Leonard B. , Schneider, Charles John , Stoffel, Elena M.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | September 5, 2019 | Volume: 17 | Issue: 9 | Pages: 1109-1133

10.6004/jnccn.2019.0043 | PMID 31487687 Get It

Small bowel adenocarcinoma (SBA) is a rare malignancy of the gastrointestinal tract that has increased in incidence across recent years. Often diagnosed at an advanced stage, outcomes for SBA are worse on average than for other related malignancies, including colorectal cancer. Due to the rarity of this disease, few studies have been done to direct optimal treatment, although recent data have shown that SBA responds to treatment differently than colorectal cancer, necessitating a separate approach to treatment. The NCCN Guidelines for Small Bowel Adenocarcinoma were created to establish an evidence-based standard of care for patients with SBA. These guidelines provide recommendations on the workup of suspected SBA, primary treatment options, adjuvant treatment, surveillance, and systemic therapy for metastatic disease. Additionally, principles of imaging and endoscopy, pathologic review, surgery, radiation therapy, and survivorship are described.
Deep Learning–Based Histopathologic Assessment of Kidney Tissue
Hermsen, Meyke , Bel, Thomas de , Boer, Marjolijn den, Steenbergen, Eric J., Florquin, Sandrine , Roelofs, Joris J. T. H. , Stegall, Mark D. , Alexander, Mariam P., Smeets, Bart , Laak, Jeroen van der , Stegall, Mark D , Kers, Jesper , Smith, Byron H. , Hilbrands, Luuk B.

Mayo Clinic

Journal of the American Society of Nephrology | September 5, 2019 | Volume: 30 | Issue: 10 | Pages: 1968-1979

10.1681/asn.2019020144 | PMID 31488607 Get It

Significance Statement Histopathologic assessment of kidney tissue currently relies on manual scoring or traditional image-processing techniques to quantify and classify tissue features, time-consuming approaches that have limited reproducibility. The authors present an alternative approach, featuring a convolutional neural network for multiclass segmentation of kidney tissue in sections stained by periodic acid–Schiff. Their findings demonstrate applicability of convolutional neural networks for tissue from multiple centers, for biopsies and nephrectomy samples, and for the analysis of both healthy and pathologic tissues. In addition, they validated the network’s results with components from the Banff classification system. Their convolutional neural network may have utility for quantitative studies involving kidney histopathology across centers and potential for application in routine diagnostics. Background The development of deep neural networks is facilitating more advanced digital analysis of histopathologic images. We trained a convolutional neural network for multiclass segmentation of digitized kidney tissue sections stained with periodic acid–Schiff (PAS). Methods We trained the network using multiclass annotations from 40 whole-slide images of stained kidney transplant biopsies and applied it to four independent data sets. We assessed multiclass segmentation performance by calculating Dice coefficients for ten tissue classes on ten transplant biopsies from the Radboud University Medical Center in Nijmegen, The Netherlands, and on ten transplant biopsies from an external center for validation. We also fully segmented 15 nephrectomy samples and calculated the network’s glomerular detection rates and compared network-based measures with visually scored histologic components (Banff classification) in 82 kidney transplant biopsies. Results The weighted mean Dice coefficients of all classes were 0.80 and 0.84 in ten kidney transplant biopsies from the Radboud center and the external center, respectively. The best segmented class was “glomeruli” in both data sets (Dice coefficients, 0.95 and 0.94, respectively), followed by “tubuli combined” and “interstitium.” The network detected 92.7% of all glomeruli in nephrectomy samples, with 10.4% false positives. In whole transplant biopsies, the mean intraclass correlation coefficient for glomerular counting performed by pathologists versus the network was 0.94. We found significant correlations between visually scored histologic components and network-based measures. Conclusions This study presents the first convolutional neural network for multiclass segmentation of PAS-stained nephrectomy samples and transplant biopsies. Our network may have utility for quantitative studies involving kidney histopathology across centers and provide opportunities for deep learning applications in routine diagnostics.
Gene Expression and Missplicing in the Corneal Endothelium of Patients With a TCF4 Trinucleotide Repeat Expansion Without Fuchs' Endothelial Corneal Dystrophy
Wieben, Eric D. , Baratz, Keith H. , Aleff, Ross A., Maguire, Leo J., Fautsch, Michael P. , Kalari, Krishna R. , Tang, Xiaojia , Patel, Sanjay V.

Mayo Clinic

Investigative Opthalmology & Visual Science | August 30, 2019 | Volume: 60 | Issue: 10 | Pages: 3636

10.1167/iovs.19-27689 | PMID 31469403 Get It

Multi‐institutional analysis of outcomes following transoral surgery for HPV‐positive oropharyngeal squamous cell carcinoma in elderly patients
Jackson, Ryan S. , Chen, Stephanie , Last, Aisling, Khan, Amish M., Kallogjeri, Dorina , Abel, Kathryn M. Van , Moore, Eric J. , Pipkorn, Patrik , Van Abel, Kathryn M

Mayo Clinic

Head & Neck | August 28, 2019 | Volume: 41 | Issue: 11 | Pages: 3933-3939

10.1002/hed.25946 | PMID 31460691 Get It

AbstractBackgroundThe incidence of human papillomavirus (HPV)‐related oropharyngeal squamous cell carcinoma (OPSCC) is rising, even in elderly patients. The outcomes of transoral surgery (TOS) in this population are not entirely known.MethodsA retrospective review was performed at two institutions from October 2003 to September 2016 on patients 70 years or older with HPV‐related OPSCC treated with TOS.ResultsA total of 75 patients were included with a mean age of 74 years (70‐87 years). At a median follow‐up of 35.7 months, 3‐year overall survival was 81.5% and disease‐specific survival was 94.3%. Advanced cT stage (odds ratio, 2.74; 95% confidence interval, 1.13‐6.64) negatively impacted OS. Conjunctive consolidation was performed to create a staging system with patients older than 80 years, severe comorbidity, and cT3‐4 having worse survival.ConclusionsElderly patients with HPV‐related OPSCC treated with TOS have excellent survival and therefore should not be excluded from such therapy based on age alone.
Estrogen Metabolism in Portopulmonary Hypertension (POPH): A Case-Control Study
Krowka, Michael J. , Forde, Kimberly A. , Bull, Todd M., Bartolome, Sonja, Lin, Grace , Oh, Jae K. , Mottram, Carl, Scanlon, Paul D., Patel, M., Fallon, Michael B. , Al‐Naamani, Nadine , Heresi, Gustavo A. , Roberts, Kari E. , Hemnes, Anna R. , Krok, Karen , DuBrock, Hilary M. , Austin, Eric , Kawut, Steven M.

Mayo Clinic

C52. USE YOUR ILLUSION II: CLINICAL RESEARCH IN PAH | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A5097-A5097

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a5097 Get It

Long Term Follow Up of Patients Receiving Intrapleural Tissue Plasminogen Activator and Deoxyribonuclease Therapy for Pleural Space Infection
Fonseca, Ximena, Sakata, Kenneth K. , Patel, Priyanka , Kern, Roshan , Midthun, David E. , Edell, Eric S. , Mullon, John J., Fonseca, X., Nelson, D., Patel, P., Singh, S., Kern, R.

Mayo Clinic

C23. PLEURAL DISEASE, CF, AND OTHER MAGICAL CREATURES | August 26, 2019 | Volume: No volume available | Issue: No issue available | Pages: A4345-A4345

10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a4345 Get It